Alligator Bioscience AB

ALLGF:Grey Market
RT Quote | Exchange | USD
Last | 02/18/20 EST
0.87UNCH (UNCH)
52 week range
0.87 - 0.87

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.87
  • 52 Week High0.87
  • 52 Week High Date02/18/20
  • 52 Week Low0.87
  • 52 Week Low Date02/18/20
  • Market Cap66.93M
  • Shares Out74.43M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-3.45
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Alligator Bioscience AB News

There is no recent news for this security.

Latest ALLGF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Alligator Bioscience AB is a Sweden-based company that is engaged in development of immunotherapies for the treatment of cancer. The Company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. In the discovery of those drugs, the Company uses its technology platforms ALLIGATOR-GOLD and FIND. ALLIGATOR-GOLD is a library containing human antibodies. FIND (which stands for Fragment Induced Diversity) is an...
Peter Benson
Chairman
Per Norlen
Chief Executive Officer
Malin Carlsson
Chief Operating Officer
Marie Svensson
Chief Financial Officer
Peter Ellmark Ph.D.
Vice President
Address
Scheelevagen 2 Byggnad 401
Lund
223 63
Sweden